Biowin members

Novadip Biosciences

Rue Granbonpré 11
1435 MONT-SAINT-GUIBERT
Belgium
[email protected] +32 10 77 92 20 www.novadip.com

Novadip develops regenerative therapies for critical bone defects, utilizing adipose-derived stem cells to accelerate healing in conditions like bone non-union and spinal fusion.

About

Related projects

Projects

Learn more

Theramir

    R&D Advanced Therapies Biopharma

En cours

Learn more

Solit

    R&D Advanced Therapies

En cours

Learn more
Exosome

Caract'exo

    R&D Advanced Therapies

En cours

Related news

News

Learn more
NVDX3-Novadip

Novadip reports key nonclinical and interim clinical data for NVDX3, its off-the-shelf allogenic product, in spine fusion

    Press release

22.04.2025

Learn more

Novadip shares positive 12-month results from phase 1b/2a trial with NVDX3 in trauma

    Press release

20.02.2025

Learn more
Novadip-NVD003-shipped-ready-for-the-implantation-to-the-patient

Novadip reports 12-month results from phase 1b/2a trial of NVD003 to treat rare pediatric disease Congenital Pseudarthrosis of the Tibia

    Press release

28.01.2025